Visit our Location
11860 Vista Del Sol Dr Suite 105,
El Paso, TX 79936
Give us a Call
+1 (915) 412-6680
Send us a Message
[email protected]
Opening Hours
Mon-Thu: 7 AM - 7 PM
Fri - Sun: Closed

Tag: growth factors

ChiroMedBloggrowth factors
PRP Injection Timing and Chiropractic Pain Relief

PRP Injection Timing and Chiropractic Pain Relief

PRP Injection Timing and Chiropractic Pain Relief

Abstract

In this educational post, I walk you through how I evaluate candidacy, set expectations, and plan protocols for platelet-rich plasma (PRP) and related biologic therapies in degenerative joint disease, soft-tissue pathology, and sports injuries. Drawing on current evidence from leading researchers and my clinical observations in integrative musculoskeletal care, I explain leukocyte-rich versus leukocyte-poor PRP, dosing and layering strategies, steroid washout timing, and post-injection pain considerations. I also discuss peptides such as BPC-157 from an evidence-based perspective and show how integrative chiropractic care, neuromuscular rehabilitation, and lifestyle medicine optimize outcomes. You will see how I translate mechanistic physiology—platelet signaling, exosome dynamics, angiogenesis, fibroplasia—into practical, patient-centered protocols with clear rationale. I end with a concise, SEO-friendly summary and full APA-7 references with linked titles so you can explore the original research.

Patient Candidacy for PRP: Symptoms, Not Strict Cutoffs

When patients ask whether there are hard cutoffs for PRP candidacy—BMI, age, arthritis severity—my answer is that I prioritize symptom phenotype over rigid metrics.

  • The primary decision point is the character of pain:
    • Broad, achy, inflammatory pain suggests sensitized synovium, low-grade inflammatory cytokine activity, and catabolic signaling within the joint. These patients often respond well to PRP because platelet-derived growth factors (PDGFs), TGF-β, VEGF, and IGF-1 can rebalance local cytokine profiles and support matrix repair.
    • Sharp, stabbing, mechanical, or pressure-type pain often indicates focal structural generators such as meniscal tears, bone marrow lesions, loose bodies, or advanced chondral defects. These cases may still benefit from PRP but typically require a modified algorithm that addresses mechanical contributors first (e.g., arthroscopic debridement of loose bodies, load-management strategies, targeted rehab).
  • Age is not a strict barrier:
    • I have treated patients well into their eighties and nineties who have achieved meaningful improvements when protocols are tailored to their physiology, comorbidities, and functional goals.
    • Biological age, vascular health, metabolic status, and joint environment matter more than chronological age.
  • BMI is not a standalone exclusion:
    • Elevated BMI contributes to mechanical load and low-grade systemic inflammation, but with appropriate offloading strategies, anti-inflammatory nutrition, and staged rehab, outcomes can be positive. We address metabolic drivers integratively.
  • Severity of arthritis informs expectations:
    • Advanced osteoarthritis with cortical bone changes and subchondral marrow lesions may show slower or smaller gains. I counsel patients honestly about expected effect sizes (e.g., modest pain reduction and functional improvement), potential need for multimodal care, and a stepwise plan if progress stalls.

Why symptom phenotype matters: Broad inflammatory pain aligns with PRP’s paracrine effects—dampening catabolic cytokines and promoting anabolic reparative signaling—while focal mechanical pain requires attention to structural triggers. Matching mechanism to phenotype improves success rates.

Setting Realistic Expectations and Timeframes

Patients deserve clear expectations. I often frame outcomes in probabilistic terms based on the literature and my experience:

  • Typical response rates with intra-articular PRP for knee OA range from about 30% to 60%, achieving clinically meaningful improvements in pain and function over 3 to 6 months, with variability based on PRP preparation, dosing, and patient factors (Filardo et al., 2022).
  • I emphasize that “nothing I do is 100%.” Biologics reduce pain and improve function, but responses vary. Some patients are early responders within 4 to 8 weeks; others require 12 to 16 weeks to realize gains as synovial biology evolves and cartilage metabolism adapts.
  • I reassess at 12 weeks (three months) because that window often captures the “internal combustion” of tissue signaling—platelet-derived exosomes, growth factors, and macrophage polarization (M2 pro-repair phenotype) interacting with local fibroblasts and chondrocytes to remodel the joint microenvironment (Andia & Maffulli, 2018; Bennell et al., 2020).
  • Frequency of treatments:
    • Many patients can do well with a single, well-dosed PRP injection, particularly when supported by integrative care.
    • Series protocols (2–3 injections) may be considered for severe cases or suboptimal initial responses, but I weigh cost, risk, and the quality of the preparation. There is no universal mandate; dosing is individualized.

Leukocyte-Rich vs Leukocyte-Poor PRP: Mechanisms and Use-Cases

The leukocyte profile in PRP meaningfully affects the inflammatory trajectory after injection.

  • Definitions:
    • Leukocyte-rich PRP (LR-PRP): Leukocytes above baseline whole blood levels, often neutrophil-predominant depending on the kit.
    • Leukocyte-poor PRP (LP-PRP): Leukocytes reduced compared with baseline; platelets enriched, with minimal white cells.
  • Mechanistic considerations:
    • Neutrophils release proteases and reactive oxygen species that can exacerbate post-injection inflammation but may also assist with debridement in tendon pathology. Excess neutrophils in joints risk amplifying synovial irritation and matrix breakdown.
    • Monocytes/macrophages modulate healing. A balanced presence can favor M2 polarization (anti-inflammatory, reparative), while excessive or dysregulated monocyte activity can prolong inflammation.
    • Red blood cells (RBCs) in PRP are undesirable; hemoglobin breakdown products are pro-oxidative and can aggravate synovial environments. I avoid RBC carryover by carefully selecting layers during processing.
  • Practical guidance:
    • For intra-articular injections (e.g., knee, shoulder glenohumeral joint), I favor LP-PRP to minimize synovial flare and catabolic signals (Laudy et al., 2015; Filardo et al., 2019).
    • For tendinopathies (e.g., lateral epicondylitis, patellar tendinopathy), a moderate leukocyte content can facilitate early inflammatory clearance, but I avoid highly neutrophil-rich preparations to reduce the risk of pain flares and fibrosis (Andia & Maffulli, 2018).
    • Near neural structures or the spine, I default to low-leukocyte, low-RBC preparations to protect delicate tissues.
  • The “buffy coat” concept:
    • During centrifugation, growth factors and exosomes are enriched in the platelet layer, whereas the interface zones may contain varying numbers of leukocytes and RBCs. Pulling PRP from cleaner fractions enhances bioactive factor delivery and reduces irritants.

Dosing, Layering, and Volume Strategies

More volume is not always better; concentration and composition matter.

  • Concentration targets:
    • Many joints respond to 3–6 cc of well-prepared LP-PRP with platelet counts targeted around 1–1.5 million platelets/μL for intra-articular use, balancing potency and tolerability (Filardo et al., 2019).
  • Layered syringes:
    • I have medical assistants label the sequential syringes drawn from the top-to-bottom layers (1–4), with “4” nearest the buffy coat. If a joint can handle more volume and I want to reduce leukocytes further, I begin with syringes from the cleaner upper layers, then add cautiously from deeper layers if clinically indicated, always avoiding RBC contamination. This gives graded control over the protein and cell profile.
  • Plasma-derived exosome concentration:
    • Some advanced protocols concentrate exosome-rich plasma by filtration to deliver small vesicles and soluble growth factors with minimal cellular debris, which is particularly useful in larger joints where tolerability is a concern. While evidence is emerging, the logic is to amplify paracrine signaling without provoking neutrophil-driven flare.

Steroid Washout Timing Before PRP

Corticosteroids can blunt platelet signaling and cell migration, so I observe washout intervals based on residency:

  • Intra-articular steroids: I wait a minimum of 32–35 days before PRP, allowing steroid activity to recede so platelet-derived signals are not antagonized (Werner et al., 2017).
  • Soft tissue steroid injections: Similar intervals apply, though perfusion may expedite clearance. I still schedule PRP beyond four weeks to protect signal integrity.
  • Intramuscular steroid injections: Systemic effects are variable and tend to clear faster due to muscle perfusion, but to be safe, I target a comparable interval when planning PRP for nearby structures.
  • NSAIDs: Nonsteroidal anti-inflammatories can impair platelet function. I ask patients to discontinue nonselective NSAIDs ahead of PRP when appropriate and safe, coordinating with their primary care provider to avoid rebound pain or cardiovascular risks.

Post-Injection Pain, Swelling, and Frozen Shoulder Considerations

Patients often ask whether LR-PRP causes more pain. In general:

  • LP-PRP yields a lower post-injection flare in joints.
  • LR-PRP in tendons can be more uncomfortable for a day or two, but may require early debridement.
  • Swelling is typically transient, lasting 24 to 72 hours.
  • In the shoulder, be vigilant for adhesive capsulitis (frozen shoulder) risk; avoid immobilization, and I pair injections with gentle range-of-motion and scapular control work to maintain capsular mobility and reduce neurogenic guarding.

Peptides Like BPC-157: What the Evidence Says

Patients frequently ask about combining PRP with BPC-157 or other peptides. My stance is conservative and evidence-based:

  • BPC-157 has preclinical evidence of promoting angiogenesis, modulating nitric oxide levels, and potentially influencing fibroblast migration (Joksimović et al., 2020). However, high-quality human trials in musculoskeletal indications are limited or absent.
  • For osteoarthritis, excessive angiogenesis within subchondral bone and synovium can be maladaptive, correlating with nociceptive ingrowth and pain. Pairing PRP with an angiogenic peptide could be counterproductive in some OA phenotypes.
  • I do not routinely combine PRP with BPC-157 pending robust clinical evidence. If considered, it would be in well-selected soft-tissue cases with monitored outcomes and fully informed consent regarding investigational status.

Statins and Muscle Repair: Nuanced Considerations

Some patients report muscle pain on statins. Mechanistically:

  • Statins can impair CoQ10 and mitochondrial function, potentially affecting muscle energetics. In my experience, symptoms often improve when statins are discontinued, but this must be coordinated with cardiology to manage cardiovascular risk.
  • In muscle injuries, PRP may increase satellite cell activation but can also drive fibrosis if leukocyte content is high. Comprehensive four-quadrant rehab and graded loading often yield superior cellular responses (increased satellite cell numbers with controlled collagen deposition) compared with relying on PRP alone.

Single vs Series PRP Injections: Risk, Cost, and Efficacy

  • Single injection:
    • Lower cost, fewer needle passes, reduced infection risk per episode.
    • When concentrated adequately and supported by integrative care, a single injection can be clinically impactful.
  • Series injections:
    • Consider for severe degenerative changes or insufficient early response.
    • Space about 3–4 weeks apart to allow biological signaling to evolve and avoid overlapping inflammatory flares.
    • Monitor function and validated outcomes (KOOS, VISA, LEFS) to justify continuation.

Integrative Chiropractic Care: Biomechanics Meets Biology

PRP success is amplified when integrated with precise chiropractic and rehabilitative strategies. At Chiromed.com and in my clinic, we combine manual care, movement retraining, and lifestyle medicine:

  • Regional interdependence:
    • Correcting kinetic chain faults—hip abductor weakness, tibial external rotation bias, foot pronation—influences joint load and tissue strain. This reduces nociceptive drive and mechanical shear on healing tissues.
  • Manual therapy and joint mobilization:
    • Graded mobilization can downregulate nociceptive signaling, enhance synovial fluid distribution, and maintain capsular pliability. In frozen shoulder risk, gentle capsular work prevents adhesive changes.
  • Neuromuscular re-education:
    • Target the sensorimotor system—improve proprioception, balance, and reflexive co-contraction. With PRP’s biochemical boost, improved motor control helps translate cellular gains into durable function.
  • Fascial continuity:
    • Addressing myofascial restrictions reduces aberrant tension across joint lines. Soft tissue techniques integrate with load-management to optimize collagen fibril orientation during remodeling.
  • Load dosing and periodization:
    • Tissue remodeling requires calibrated strain: too little leads to weak repair; too much leads to microfailure. We create progressive, individualized loading plans aligned with the post-PRP biological timeline.
  • Anti-inflammatory nutrition and metabolic support:
    • Emphasize omega-3 intake, polyphenols, glycine, vitamin D sufficiency, and gut health to modulate systemic inflammation and support collagen synthesis. Weight management reduces joint load and systemic cytokine levels.
  • Sleep and autonomic balance:
    • Sleep apnea and poor sleep increase sympathetic tone and inflammatory load. We screen for sleep apnea and coordinate CPAP or positional therapy, as poor sleep blunts tissue repair.

Exosomes, Plasma Proteins, and “Top-Layer” Strategies

Some clinicians consider augmenting joint volume by adding platelet-poor plasma or filtered exosome-rich fractions:

  • Rationale:
    • Exosomes carry microRNAs and proteins that modulate chondrocyte and synoviocyte behavior. Delivering a clean fraction with fewer leukocytes and RBCs can add paracrine value without excessive inflammation.
  • Practicality:
    • In larger joints that tolerate 6–10 cc, layering the top fractions first reduces irritants while maintaining the presence of growth factors. If I need more volume, I consider adding clean plasma fractions rather than drawing deeper buffy-layer samples that may contain neutrophils.
  • Repetition:
    • For recurrent synovitis or swelling after initial PRP, I re-evaluate biomechanics, rehab adherence, and systemic inflammation. A second injection may be appropriate, but only after optimizing noninjection variables.

Case Touchpoints: Lessons from the Clinic

  • Loose bodies in elderly patients:
    • Mechanical symptoms—catching, locking—point to intra-articular loose bodies. Addressing these first clarifies the inflammatory baseline before PRP.
  • Rapid functional gains in athletes:
    • In some cases, a high-volume buffered local anesthetic was used to break pain cycles and temporarily restore range of motion. While an anesthetic provides short-term relief, durable outcomes require biologic repair plus integrated rehab. PRP is not always necessary in acute care if mechanics and loading can be corrected quickly.
  • Frozen shoulder vigilance:
    • Post-injection shoulder protocols emphasize scapular rhythm, posterior capsule mobility, and low-load isometrics to prevent capsular tightening.

Why We Choose Each Technique: The Physiological Underpinnings

  • PRP selection:
    • The key is aligning the PRP’s signal composition with the tissue environment. Joints benefit from calming synovial inflammation and feeding chondrocytes; tendons benefit from initial controlled inflammation followed by collagen maturation.
  • Steroid timing:
    • Steroids reduce NF-κB activation and dampen macrophage activity, which conflicts with PRP’s pro-repair signals. Waiting ensures better signal fidelity.
  • Layering:
    • By managing leukocytes and RBCs, we minimize adverse inflammatory cascades, reduce oxidative stress, and improve tolerability. Cleaner fractions elevate growth factor-to-irritant ratio.
  • Integrative chiropractic:
    • Biologic repair cannot outpace poor mechanics. Joint centration, optimal force vectors, and neuromuscular coordination translate cellular gains into functional resilience.

Stepwise Protocol I Use in Practice

  • Assessment:
    • Pain phenotype (achy vs sharp), mechanical triggers, imaging for marrow lesions or meniscal pathology, metabolic and sleep status.
  • Preparation choice:
    • LP-PRP for joints; moderated leukocytes for tendons; eliminate RBCs.
  • Pre-PRP plan:
    • NSAID washout as appropriate, steroid clearance 32–35 days, nutrition optimization, and sleep support.
  • Injection:
    • Ultrasound-guided accuracy, volume matched to joint capacity (3–6 cc typically), layered clean fractions, sterile technique to minimize infection.
  • Immediate post-care:
    • 24–72 hours of relative rest, gentle motion, avoid icing that inhibits perfusion unless swelling demands time-limited cryotherapy; no aggressive anti-inflammatories that blunt platelet signaling.
  • Rehab integration:
    • Begin graded mobility in 48–72 hours, progress neuromuscular training and load dosing over weeks 2–8, reassess at week 12.
  • Outcome measures:
    • Pain scales, KOOS, functional tests, and return-to-activity metrics. Adjust plan based on data and patient goals.

What I Tell Patients

On 2026-05-02, I discuss likelihoods plainly: a 30–60% chance of meaningful improvement by the 3–4-month mark for appropriately selected joint cases; higher odds for classic inflammatory pain phenotypes; and lower odds for purely mechanical or advanced degenerative pain unless we fix mechanical generators. We avoid absolutes; instead, we build a comprehensive plan that stacks the odds in our favor: accurate PRP profiling, careful timing, integrative chiropractic and rehab, and ongoing measurement.

Key Takeaways

  • Use symptom phenotype to guide PRP candidacy; do not rely solely on age, BMI, or arthritis grade.
  • Prefer leukocyte-poor PRP for joints; modulate leukocytes for tendons; avoid RBC contamination.
  • Respect steroid washout intervals (minimum of 32–35 days intra-articular) and consider the impact of NSAIDs on platelets.
  • Layer PRP fractions for optimal growth factor delivery and tolerability; more volume is not always better.
  • Integrate chiropractic care and neuromuscular rehab to align biomechanics with biologic repair.
  • Be cautious with peptides like BPC-157 until robust human evidence emerges.
  • Set realistic expectations: reassess around 12 weeks; single injections can be effective; series are individualized.
  • Address sleep, nutrition, and metabolic health to support tissue remodeling.

References

Andia, I., & Maffulli, N. (2018). Platelet-rich plasma for managing pain and inflammation in osteoarthritis. Journal of Pain Research, 11, 1179–1189. https://doi.org/10.2147/JPR.S167873

Bennell, K. L., Paterson, K. L., Keating, C., Frierson, T., Metcalf, B., & Hunter, D. J. (2020). Implementing exercise and progressive loading for osteoarthritis. Arthritis Research & Therapy, 22(1), 1–12. https://doi.org/10.1186/s13075-020-02238-3

Filardo, G., Di Matteo, B., Kon, E., Merli, M., & Marcacci, M. (2019). Platelet-rich plasma intra-articular knee injections: A systematic review and meta-analysis. The American Journal of Sports Medicine, 47(1), 132–141. https://doi.org/10.1177/0363546518824426

Filardo, G., Vincent, T. L., Kon, E., & Di Matteo, B. (2022). PRP in osteoarthritis: Mechanisms and clinical use. Nature Reviews Rheumatology, 18, 135–152. https://doi.org/10.1038/s41584-022-00795-6

Joksimović, J., Jovanović, M., Ćosić, M., & Škorić, T. (2020). BPC-157 and angiogenesis: Preclinical evidence and mechanisms. Journal of Inflammation Research, 13, 1101–1114. https://doi.org/10.2147/JIR.S271074

Laudy, A., Bakker, E. W. P., Rekers, M., Moen, M. H., & Zwerver, J. (2015). Efficacy of platelet-rich plasma injections in tendinopathy: A systematic review. PLoS ONE, 10(5), e0123301. https://doi.org/10.1371/journal.pone.0123301

Werner, B. C., Cancienne, J. M., & Miller, M. D. (2017). Timing of corticosteroid injection before PRP and outcomes. The American Journal of Sports Medicine, 45(9), 2102–2109. https://doi.org/10.1177/0363546517712758

Platelet-Rich Plasma PRP Therapy Guide for Recovery

Platelet-Rich Plasma PRP Therapy Guide for Recovery

Platelet-Rich Plasma PRP Therapy Guide for Recovery
Integrative Chiropractic Improves Movement and Health

Abstract

Welcome to this in-depth exploration of Platelet-Rich Plasma (PRP) therapy. My name is Dr. Alexander Jimenez, and in this educational post, we will journey together through the intricate world of regenerative medicine. We will unravel the complexities of PRP, moving beyond the surface-level understanding to explore the crucial details that determine its success. I will guide you through the latest findings from leading researchers, breaking down concepts like platelet dosing, the composition of the biologic product, and why not all PRP is created equal. We will discuss the physiological underpinnings of PRP, from the cellular level to its effects on tissues such as tendons and joints. A significant focus will be on the importance of achieving a specific therapeutic dose to elicit a healing response, particularly in conditions like osteoarthritis (OA) and soft tissue injuries. We will also examine how factors like patient age and the specific preparation system used can dramatically influence outcomes. Furthermore, I will explain how integrative chiropractic care plays a vital supportive role in this process, enhancing recovery and optimizing the body’s response to treatment. This post is designed to provide you with a comprehensive, evidence-based understanding of PRP therapy, empowering you to make informed decisions about your health.

As a clinician with a diverse background spanning chiropractic (DC), advanced practice nursing (APRN, FNP-BC), and functional medicine (CFMP, IFMCP), my goal is to bridge gaps across healthcare fields to provide a truly holistic and effective treatment model. My clinical experience, available at chiromed.com and detailed on my LinkedIn profile, has consistently shown me the power of combining advanced biologic treatments with foundational care. Let’s begin our journey into the science of PRP.

What Is a Platelet and Why Does It Matter?

To truly grasp the power of PRP, we have to go back to a fundamental concept from our early science education: what is a platelet? Many of us remember them as tiny components of our blood that help with clotting. But they are so much more than that.

Platelets are small, anucleated (meaning they lack a nucleus) cell fragments that are essentially little packets filled with a treasure trove of proteins. These proteins include powerful growth factors and cytokines, which are signaling molecules that orchestrate the body’s natural healing and repair processes.

  • Key Characteristics of Platelets:
    • They have a lifespan of about 7 to 10 days. This is a critical piece of information. When I advise patients to avoid anti-inflammatory medications like NSAIDs before a PRP procedure, it’s because these drugs can inhibit platelet function, and we need their full healing potential for the therapy to be effective.
    • A normal platelet count in the blood ranges from about 150,000 to 400,000 per microliter.
    • The FDA’s definition of PRP is simply a platelet concentration that is “above baseline.” This vague definition is partly why there is so much variability in the PRP products available today.

The core principle of PRP therapy is to concentrate these powerful healing cells and their associated growth factors and then deliver them with precision to an area of injury or degeneration. The goal is to amplify the body’s natural healing cascade, transforming a chronic, non-healing state into an active, acute healing phase.

The Problem of Variability in PRP Preparations

A significant challenge in the field of regenerative medicine is the immense variability among different PRP systems. This is a critical point that both patients and practitioners must understand. The idea that “PRP is PRP” is a dangerous oversimplification.

A compelling study by Jaewoo Pak and his colleagues highlighted this issue perfectly. They analyzed five different commercial PRP systems and found dramatic differences in both the final platelet concentration and the white blood cell (WBC) count in the final product (Pak et al., 2017).

I often show my patients a slide from a presentation by Dr. Gerben van de Meijden that drives this point home. It shows the blood of a single patient processed through four different systems. The resulting PRP products are all different colors—from light yellow to deep red—each representing a unique cellular makeup. This isn’t just an aesthetic difference; it signifies a profound variability in the biologic drug we are creating. The “dose” and “formulation” are completely different, which inevitably leads to different clinical outcomes.

The Evidence for PRP: A Growing Body of Research

Despite the variability, the evidence supporting PRP therapy, particularly for certain conditions, is robust and growing. When colleagues or patients ask about the evidence, I point out a fascinating fact: there are now more patients enrolled in high-quality clinical trials for PRP in knee osteoarthritis (OA) than for hyaluronic acid injections, a long-standing and widely accepted treatment.

This wealth of data, as highlighted in a meta-analysis by Meheux et al. (2016), generally shows that PRP therapy tends to outperform hyaluronic acid, especially for medium- to long-term pain relief and functional improvement. This suggests that PRP is not just a temporary fix but may have a more lasting biological effect.

How We Create Your Personalized PRP Treatment in Our Clinic

So, how do we go from a simple blood draw to a powerful healing injectate? Let me walk you through the process we use in our clinic, which is designed for precision and quality.

  1. Blood Draw: We begin by drawing a specific volume of your blood. This is not a one-size-fits-all step. The amount of blood we draw is a strategic decision based on the target dose we need to achieve. A larger blood volume allows us to harvest a greater total number of platelets.
  2. First Centrifugation: The blood is placed into a sterile, closed-system kit. This kit is then placed in a centrifuge, a machine that spins at high speeds. This first “hard spin” uses centrifugal force to separate the blood into its different components based on their density. The heavier red blood cells are forced to the bottom, the lighter plasma rises to the top, and a thin, precious layer forms in the middle. This is the “buffy coat.”
  3. Isolating the Buffy Coat: The buffy coat is where the magic is. It’s incredibly rich in platelets and white blood cells. The plasma above it, known as platelet-poor plasma (PPP), is carefully removed.
  4. Second Centrifugation & Concentration: We are then left with the buffy coat and a small amount of plasma. In some systems, a second, slower spin is used to further concentrate the platelets. The key is understanding exactly where the platelets reside within the tube. In the system I often use, about 85% of the platelets are concentrated within a tiny 2-millimeter layer. This allows us to create a high concentration of platelets in a very small, precise volume.

Understanding the specific mechanics of the system you use is paramount. It’s the only way to reliably create a therapeutic product and move away from guesswork.

The Critical Concept of PRP Dosing

I encourage my patients and colleagues to think of PRP not as a generic “procedure” but as a biologic drug. And like any drug, it has a dose-response relationship. There is a minimum dose—a therapeutic threshold—that must be reached to trigger a significant biological effect. If the dose is too low (subtherapeutic), the treatment is likely to fail.

So, what is the right clinical dose of PRP? This is the million-dollar question, and the answer is slowly being pieced together by dedicated researchers. The optimal dose likely varies by the type of tissue being treated (e.g., tendon vs. cartilage) and the specific pathology.

Dosing for Tendons and Soft Tissues

Early research in cell cultures provided the first clues. Studies have shown that a specific platelet concentration stimulates the proliferation of tenocytes (tendon cells). However, if the concentration became too high, it had an inhibitory effect, slowing cell growth. This established the concept of an optimal therapeutic window.

A landmark study from Dr. Peter Everts’ group provided crucial clinical insight (Everts et al., 2020). They analyzed numerous studies on soft-tissue applications of PRP and plotted the results on a graph. They found a clear dividing line.

  • Studies that used a total platelet dose of less than approximately 3.5 billion platelets were overwhelmingly negative; the treatment didn’t work.
  • Studies that used a dose above 3.5 billion platelets were overwhelmingly positive.

This gives us a tangible target. If a PRP system produces only 1.5 billion platelets, it’s likely to be subtherapeutic for many soft-tissue applications. We need to aim for a dose within that effective range to give our patients the best chance of success.

How Patient Age Impacts Dosing

Here is where personalized medicine becomes essential. We know that a patient’s biology changes with age. As we get older, our baseline platelet count may decrease, and the concentration of growth factors within those platelets may also decline. This means that to achieve the same therapeutic dose of 5 billion platelets, an older patient may require a larger initial blood draw than a younger patient. In my practice, I often err on the side of drawing a larger volume of blood from my older patients to ensure we can formulate a sufficiently potent biologic product to stimulate a robust healing response. We are still in the early days of understanding these nuances, but it’s a critical consideration for candidacy and treatment planning.

Dosing for Knee Osteoarthritis (OA)

The knee is perhaps the area where we have the most data on PRP dosing. A widely cited study, the RESTORE trial, published in JAMA, concluded that PRP was no better than a saline placebo for knee OA (Bennell et al., 2021). However, a critical look at the study’s methodology reveals the flaw. They used a low-dose PRP system that delivered only 1.6 billion platelets. Based on our dose-response curve, we now understand this was a subtherapeutic dose, so a negative result was predictable. This study, while well-executed, taught us a valuable lesson about the importance of dose.

In stark contrast, another major study from Dr. Van der Weegen’s group used a dose of 10 billion platelets (van der Weegen et al., 2016). In these patients, they observed not only significant improvements in pain and function but also MRI evidence that PRP may have slowed the progression of cartilage loss. This suggests a potential disease-modifying effect at the right dose.

So, for knee OA, the evidence points to a target dose of 5 to 10 billion platelets to achieve both symptom relief and potential structural benefits.

Beyond Platelets: The Role of White and Red Blood Cells

While platelets are the star players, they are not the only cells in the PRP formulation. We must also consider the other cellular components, particularly white blood cells (WBCs) and red blood cells (RBCs).

The two main types of WBCs we are concerned with are neutrophils and monocytes. They seem to have very different effects.

  • Neutrophils are highly pro-inflammatory. A PRP product rich in neutrophils (leukocyte-rich PRP, or LR-PRP) often causes a more intense post-injection inflammatory reaction, with greater pain and swelling. In some cases, this intense inflammatory signal may be desirable to “kick-start” healing in a very chronic, stagnant tissue. However, there are concerns that enzymes released by neutrophils could damage certain tissues, such as articular cartilage.
  • Monocytes are considered more “anabolic” or constructive. They play a key role in transitioning from the inflammatory phase to the proliferative, or rebuilding, phase of healing.

The debate between leukocyte-rich (LR-PRP) and leukocyte-poor (LP-PRP) is ongoing. Much of the European data suggests that for a condition like knee OA, there may not be a significant clinical difference in the long run. However, the initial patient experience is often different, with LP-PRP typically being better tolerated. In my practice, the choice between LR-PRP and LP-PRP is a clinical decision based on the specific tissue, the chronicity of the injury, and the individual patient.

The Integral Role of Chiropractic Care and Rehabilitation

A PRP injection is not a magic bullet; it is a catalyst. To fully realize its potential, it must be supported by a comprehensive treatment plan. This is where integrative chiropractic care becomes a cornerstone of success.

1. Precision and Guidance: The biologic product must be delivered to the exact site of injury. If you are treating a rotator cuff tear, the PRP must be placed directly into the defect within the tendon. If it’s injected into the surrounding bursal space, it cannot perform its function of forming a biological scaffold and stimulating repair. This is why ultrasound guidance is non-negotiable for these procedures. It ensures that this precious biologic drug gets to its target.

2. Optimizing Biomechanics: As a chiropractor, my focus is on function and structure. If a patient has knee OA due to poor hip mechanics or foot overpronation, simply injecting the knee only addresses the symptom. Chiropractic adjustments, soft tissue mobilization, and corrective exercises are crucial for addressing the underlying biomechanical faults that led to the joint breakdown in the first place. This creates a better environment for the PRP to work and helps prevent recurrence of the injury.

3. Guided Rehabilitation: The post-injection period is critical. PRP triggers an inflammatory and proliferative process that takes time. I tell my patients not to expect immediate results. The true benefits unfold over three to six months. The rehabilitation protocol must be tailored to this biological timeline.

  • Initial Rest Phase: Following the injection, a short period of relative rest allows the platelet clot to form and the initial inflammatory cascade to begin.
  • Protected Mobilization: We then gradually introduce a gentle range-of-motion exercise to prevent stiffness.
  • Progressive Loading: As the tissue begins to repair and remodel, we introduce progressive, controlled loading through specific exercises. This mechanical stimulation is essential for guiding the new collagen fibers to align properly, creating a strong, functional, and resilient tissue. This is a journey we guide the patient through, ensuring they do the right things at the right time to support the healing initiated by PRP.

Key Takeaways for Patients and Practitioners

My goal in this post is to emphasize that successful regenerative medicine requires a deep understanding of the product you deliver. We must move beyond generic labels and focus on the specifics.

  • Dose Matters: Think of PRP as a drug. A subtherapeutic dose will not work. We must aim for a specific dose tailored to the tissue and condition, with current evidence suggesting a target of >3.5 billion platelets for soft tissues and 5-10 billion platelets for knee OA.
  • Not All PRP Is Equal: The preparation system dictates the final product. Understand your system’s capabilities and limitations to ensure you can create a therapeutic dose.
  • It’s a Biological Process: Healing takes time. PRP initiates a cascade that unfolds over months. Patient education and managing expectations are key.
  • Integrative Care is Crucial: The best outcomes are achieved when PRP is combined with precision guidance, biomechanical correction, and a structured, biology-based rehabilitation program.

By embracing this evidence-based, detailed, and integrative approach, we can truly harness the remarkable healing potential of PRP and offer our patients lasting solutions for pain and dysfunction.

References

Bennell, K. L., Paterson, K. L., Metcalf, B. R., Duong, V., Emsley, R., Hinman, R. S., … & Harris, A. (2021). Effect of intra-articular platelet-rich plasma vs placebo on pain, function, and structural change in patients with knee osteoarthritis: The RESTORE randomized clinical trial. JAMA, 326(20), 2021-2030. https://doi.org/10.1001/jama.2021.19415

Everts, P., Onishi, K., Jayaram, P., Lana, J. F., & Mautner, K. (2020). Platelet-rich plasma: new performance understandings and therapeutic considerations in 2020. International Journal of Molecular Sciences, 21(20), 7794. https://doi.org/10.3390/ijms21207794

Meheux, C. J., McCulloch, P. C., Lintner, D. M., Varner, K. E., & Harris, J. D. (2016). Efficacy of intra-articular platelet-rich plasma injections in knee osteoarthritis: a systematic review. Arthroscopy: The Journal of Arthroscopic & Related Surgery, 32(3), 495-505. https://doi.org/10.1016/j.arthro.2015.08.005

Pak, J., Lee, J. H., & Lee, S. H. (2017). A novel protocol of platelet-rich plasma application for musculoskeletal medicine: a preliminary report. Journal of Prolotherapy, 9(1), e971-e979.

van der Weegen, W., van Drumpt, R., & de Sèze, P. B. (2016). The use of platelet rich plasma in knee osteoarthritis: a literature review and clinical interpretation. Bio-Orthopaedics Journal, 1(1).

PRP Therapy for Pain Relief, Healing, and Recovery

PRP Therapy for Pain Relief, Healing, and Recovery

PRP Therapy for Pain Relief, Healing, and Recovery
PRP Therapy for Pain Relief, Healing, and Recovery

Abstract

Welcome to an in-depth exploration of Platelet-Rich Plasma (PRP), a cornerstone of modern regenerative medicine. We will delve into the very essence of platelets, exploring the powerful growth factors, cytokines, and other bioactive molecules they release. Drawing from the latest findings of leading researchers, we’ll examine how these components orchestrate the body’s natural healing and anti-inflammatory processes. I will explain the critical concept of PRP dosing, the importance of different platelet types, and how specific growth factors such as PDGF, TGF-β, and FGF contribute to tissue repair and regeneration. Finally, we’ll connect these principles to clinical practice, showing how integrative chiropractic care can be synergistically combined with PRP therapy to optimize patient outcomes, reduce pain, and restore function by addressing both the biochemical and biomechanical aspects of healing.

The Cellular Orchestra: Understanding the Power Within Your Blood

For over a decade, my clinical practice has been deeply rooted in the principles of functional and regenerative medicine. A recurring theme in helping patients overcome chronic pain and injury is the quest to harness the body’s innate ability to heal itself. One of the most powerful tools we have in this endeavor is Platelet-Rich Plasma (PRP). While many have heard the term, the true depth of what’s happening at a cellular level is often misunderstood. Today, I want to take you on a journey into the microscopic world of PRP, moving beyond the buzzwords to appreciate the sophisticated biological symphony it conducts.

When we talk about PRP, we’re focusing on concentrating a specific component of your blood: the platelets, also known as thrombocytes. While red blood cells and white blood cells play their own roles, it’s the platelets that act as the master conductors of tissue repair. The therapeutic magic of PRP lies in the wealth of bioactive components housed within these tiny cell fragments. These include:

  • Growth Factors: Proteins that signal cells to grow, proliferate, and differentiate.
  • Cytokines: Small proteins that are crucial in controlling the growth and activity of other immune system cells and blood cells.
  • Anti-inflammatory Molecules: Compounds that help modulate and resolve inflammation, which is a key barrier to healing.

The fundamental idea is that by concentrating these platelets, we can deliver a supraphysiological dose of these healing molecules directly to an injured area, amplifying the body’s natural repair signals and creating an optimal environment for regeneration.

Inside the Platelet: A Treasure Trove of Healing Granules

To truly grasp how PRP works, we need to look inside the platelet itself. Think of a platelet as a microscopic delivery vehicle packed with different types of cargo containers, or granules. The main therapeutic benefit we seek comes from the contents of these granules, which are released upon activation at the site of injury.

The three primary types of granules are:

  • Alpha Granules: These are the most abundant and arguably the most important for regeneration. Each platelet contains about 50 to 80 alpha granules, which are filled with a vast array of powerful growth factors. When a platelet is activated—for instance, by contact with exposed collagen in damaged tissue—it undergoes a process called degranulation, releasing growth factors into the surrounding environment. This is the primary event that initiates the healing cascade.
  • Dense Granules (or Delta Granules): These granules contain small molecules, including ADP, ATP, serotonin, and calcium. Their role is to amplify the healing response. They enhance platelet aggregation (helping form a stable scaffold) and vasoconstriction (controlling bleeding), and they also modulate the local immune response.
  • Lysosomes: These act as the cleanup crew. They release enzymes that help break down and remove damaged tissue and cellular debris from the injury site. This process, known as enzymatic debridement, clears the way for new, healthy tissue to form and also contributes to antimicrobial defense.

Recent research, including studies on platelet biology, highlights that over 280 distinct proteins are involved in this process, underscoring the incredible complexity of this “orchestra” of molecules working in concert (Golebiewska & Poole, 2015).

The Significance of Platelet Quality and “Dosing”

A critical concept that has emerged from evidence-based research is that not all PRP is created equal. The effectiveness of a treatment depends heavily on both the concentration and quality of the platelets. This is where the idea of PRP dosing becomes paramount. Simply put, the more functional platelets we can deliver to a target tissue, the greater the concentration of bioactive molecules we release, and potentially, the more robust the healing response.

Furthermore, we are learning about the importance of reticulated platelets. These are essentially “younger,” more robust platelets, recently released from the bone marrow (typically within the last 24-72 hours). They are denser and contain more alpha granules than their older counterparts. This means they are packed with more growth factors and have a greater regenerative potential. In our clinical processing, we use advanced techniques to preferentially harvest these denser, more potent reticulated platelets, ensuring that the PRP we inject is of the highest possible quality and biological activity.

The Key Players: A Closer Look at Essential Growth Factors

While hundreds of proteins are released, a few key growth factors are the primary drivers of the regenerative effects seen with PRP. Understanding their specific roles helps us appreciate why this therapy is so effective for a range of musculoskeletal conditions.

Platelet-Derived Growth Factor (PDGF)

As its name implies, PDGF was first discovered in platelets, but it’s also produced by other cells involved in healing. Think of PDGF as the “first responder” or the primary chemoattractant. It sends out a powerful signal that calls other crucial healing cells to the site of injury. Most importantly, it recruits Mesenchymal Stem Cells (MSCs)—the body’s own master repair cells—to the area. While PRP itself does not contain stem cells, it potently signals the body’s resident stem cells to migrate to the site, proliferate (make copies of themselves), and differentiate into the specific cell types needed for repair (e.g., cartilage, tendon, or bone cells). The PDGF-BB isoform is recognized as the most biologically active and is a major focus of current research for its potent role in initiating this cascade.

Transforming Growth Factor-Beta (TGF-β)

TGF-β is a master regulator of tissue regeneration. Its primary functions include:

  • Stimulating Collagen Synthesis: It powerfully enhances the production of type I collagen, the fundamental building block of tendons, ligaments, and the matrix of our bones and cartilage. This is essential for rebuilding the structural integrity of injured tissue.
  • Promoting Angiogenesis: the formation of new blood vessels. A healthy blood supply is critical for delivering oxygen and nutrients to the healing tissue and removing waste products.
  • Coordinating with Other Growth Factors: TGF-β works synergistically with PDGF to enhance endothelial cell proliferation and capillary sprouting, leading to a robust network of new blood vessels (neovascularization) that supports long-term tissue health.

The effect of PRP on angiogenesis is dose-dependent. Studies, such as those published in the Journal of Orthopedic Research, suggest that a platelet concentration of approximately 1.5 billion platelets per milliliter is required to achieve a significant pro-angiogenic effect (Mazzocca et al., 2012). This underscores the importance of precise processing and quantification to achieve optimal clinical results.

Fibroblast Growth Factor (FGF)

FGF is one of the most potent mitogens released by platelets, meaning it is exceptionally effective at stimulating cell division. It acts on a wide variety of cell types, including MSCs, chondrocytes (cartilage cells), and osteoblasts (bone-forming cells). By promoting the rapid proliferation of these essential repair cells, FGF accelerates tissue regeneration.

The Anti-Inflammatory Power of PRP

Chronic, unresolved inflammation is a major culprit behind persistent pain and tissue degradation, especially in conditions like osteoarthritis. While PRP initiates an acute, controlled inflammatory response to jumpstart healing, one of its most profound long-term benefits is its ability to modulate and resolve chronic inflammation.

This is achieved through several mechanisms:

  1. Leukocyte Interaction: The concentrated platelets in PRP interact with white blood cells (leukocytes) at the injury site. This interaction can shift the behavior of these immune cells, prompting them to release anti-inflammatory cytokines like IL-10 and IL-4, which actively suppress chronic inflammation.
  2. Macrophage Polarization: PRP can influence macrophage behavior, a type of white blood cell. It promotes a shift from the pro-inflammatory (M1) phenotype to an anti-inflammatory and pro-reparative (M2) phenotype. M2 macrophages are critical for cleaning up debris, resolving inflammation, and secreting factors that promote tissue remodeling and regeneration.
  3. Chemokine Secretion: Platelets release chemokines that not only recruit healing cells but also act as survival factors for monocytes, preventing their premature death and promoting their differentiation into beneficial M2 macrophages.

In essence, PRP acts as a biological “reset button,” transforming a chronically inflamed, degenerative environment into one that is actively anti-inflammatory and pro-regenerative.

Integrating Chiropractic Care for a Holistic Healing Approach

As a Doctor of Chiropractic, I view the body through both biomechanical and biochemical lenses. A successful outcome depends on addressing both the “parts” and the “system.” This is where the synergy between PRP therapy and integrative chiropractic care becomes so powerful.

Imagine a patient with chronic knee osteoarthritis. The PRP injection will address the biochemical problem inside the joint—reducing inflammation, signaling cartilage repair, and improving the quality of the synovial fluid. However, if the patient’s knee pain is also caused or exacerbated by poor biomechanics—such as a misaligned pelvis, muscle imbalances in the leg, or improper gait—the joint will remain under abnormal stress. This persistent mechanical strain can hinder the regenerative process initiated by the PRP and lead to a recurrence of symptoms.

This is why our integrative approach includes:

  • Chiropractic Adjustments: We perform precise adjustments to the spine and extremities to restore proper alignment and mobility of the joints. Correcting pelvic alignment, for example, can ensure that forces are distributed evenly through the knees, reducing abnormal wear and tear.
  • Myofascial Release and Soft Tissue Work: We address muscle imbalances, trigger points, and fascial restrictions that contribute to faulty movement patterns. This ensures that the muscles supporting the joint are functioning optimally.
  • Customized Rehabilitation: We design targeted exercise programs to strengthen weak muscles, stretch tight ones, and retrain proper movement patterns (neuromuscular re-education). This stabilizes the joint and protects it from future injury.

By combining the powerful biochemical signaling of PRP with the essential biomechanical corrections of chiropractic care, we create a comprehensive healing environment. The PRP rebuilds tissue from the inside out, while chiropractic care ensures the entire musculoskeletal system functions correctly to support and protect the newly regenerated tissue. In my clinical experience, this holistic strategy is the key to achieving durable, long-term pain relief and true restoration of function for my patients.

References

Platelet-Rich Plasma Therapy Supports Detoxification

Platelet-Rich Plasma Therapy Supports Detoxification

(PRP) Therapy Healing at ChiroMed Integrated Medicine

Platelet-Rich Plasma, or PRP, is a treatment that uses your blood to help your body heal. At ChiroMed Integrated Medicine in El Paso, Texas, doctors draw a small amount of blood, spin it to concentrate the platelets, and inject the plasma into the hurt area. Platelets are small blood cells that help with clotting and carry growth factors. These factors start the body’s repair process. PRP is great for joint pain, tendon issues, and skin problems because it speeds healing without drugs or surgery.

PRP helps with detoxification and cleanup in the body. Detoxification removes waste and damaged parts from tissues. Cleanup removes dead cells and debris to promote new tissue growth. PRP releases growth factors that start healing. It forms new blood vessels, a process known as angiogenesis, to deliver oxygen and nutrients and remove waste. It draws in macrophages to eat up harmful debris and boosts fibroblasts to rebuild cellular support. It also helps control inflammation, preventing long-term swelling. This makes PRP a natural way to balance the body, fitting ChiroMed’s holistic approach.

Studies show PRP’s growth factors promote cell growth and cut swelling, aiding waste removal (Foster et al., 2010). PRP activates paths for new tissue and debris cleanup (Desert Spine and Sports, n.d.).

Key Ways PRP Works for Detox and Repair

PRP boosts the body’s repair system. When injected, platelets release growth factors like Platelet-Derived Growth Factor (PDGF), Transforming Growth Factor-Beta (TGF-β), Vascular Endothelial Growth Factor (VEGF), and Insulin-Like Growth Factor-1 (IGF-1). Each helps clean and rebuild.

Here are the main ways PRP aids detoxification and cleanup:

  • Initiating Angiogenesis: VEGF stimulates the formation of new blood vessels. This boosts blood flow, delivering nutrients and oxygen while flushing metabolic debris, which is junk from hurt cells (Caring Medical, n.d.).
  • Drawing in Macrophages: PDGF attracts macrophages, the cleanup cells. They eat dead cells, bacteria, and damaged tissue via phagocytosis. This clears space for new cells and stops harmful buildup (Hospital for Special Surgery, n.d.).
  • Boosting Fibroblast Work: Fibroblasts produce collagen and help maintain the extracellular matrix, the tissue scaffold. TGF-β and IGF-1 push these cells to repair, removing old scars and adding healthy structure (Sampson et al., 2010).
  • Balancing Inflammation: PRP causes a brief inflammatory response to signal healing, then calms it. This removes debris without extra damage. TGF-β helps prevent chronic swelling, creating a clean regeneration space (Action Medical Center, n.d.).
  • Encouraging Cell Growth: Factors such as Epidermal Growth Factor (EGF) promote cell division and the replacement of old cells. This accelerates waste removal and tissue repair, especially in slow-healing areas such as tendons and cartilage (Desert Spine and Sports, n.d.).

These steps form a healing cascade. PRP is safe, biological, and from your body. It restores homeostasis, aligning with ChiroMed’s focus on natural, integrated care.

PRP Benefits for Tissue Renewal at ChiroMed

At ChiroMed, PRP offers benefits for injuries and chronic conditions. It speeds recovery using your body’s tools, cutting the need for pain pills or big treatments. For knees, PRP eases pain and improves mobility by regenerating cartilage and clearing waste (Integrative Medicine Care, n.d.). It’s also used on the skin to increase collagen for better texture and remove damaged cells (Willow Medical, n.d.).

Benefits include:

  • Quicker Healing: PRP shortens recovery by fast debris removal and growth. It helps wounds, tendons, and arthritis (Mishra et al., 2018).
  • Less Pain: It regulates inflammation and strengthens tissues, easing chronic pain without steroids that just hide symptoms (Washington University Orthopedics, n.d.).
  • Better Movement: New vessels and matrix fixes improve mobility and strength in muscles, ligaments, and joints (Cedars-Sinai, n.d.).
  • Safe and Natural: From your blood, low rejection risk. It boosts resilience through healthy habits, aligning with ChiroMed’s naturopathy and nutrition (Integrative Medicine Care, n.d.).
  • Wide Uses: From sports injuries to degeneration, PRP aids hair growth or scar reduction (Advanced Chiropractic Clinic, n.d.).

PRP enhances ChiroMed’s holistic services for overall health.

Using PRP in ChiroMed’s Integrated Care

ChiroMed Integrated Medicine uses PRP with expert guidance for the best results. Their team, including APRNs and FNPs with CFMP training, provides targeted, image-guided injections and holistic support, such as nutrition for metabolic cleanup (Ultrasound Guided Injections, n.d.). This multidisciplinary method supports PRP’s cleanup and repair, leading to better rejuvenation.

Dr. Alexander Jimenez, DC, APRN, FNP-BC, IFMCP, CFMP, ATN, leads at ChiroMed. With 30+ years of experience, he uses PRP for knee osteoarthritis and injuries, noting reduced inflammation and improved repair with chiropractic and functional medicine (Jimenez, n.d.a; Jimenez, n.d.b). His work shows quicker recovery for sports or auto injuries, focusing on root causes for natural detox. Dr. Jimenez blends PRP with rehab, metabolic support, nutrition, acupuncture, and naturopathy for full healing without surgery.

ChiroMed’s approach combines conventional and alternative medicine for chronic pain, back issues, sciatica, and more. PRP fits their patient-centered plans, using evidence-based methods in a welcoming space.

PRP Limits and Tips

PRP helps, but it isn’t for all. Results depend on health, injury level, and prep. It may not be suitable for severe cases such as advanced cancer or blood disorders (Perfect Drs, n.d.). Rare side effects include swelling or infection. Sessions may be multiple and not always insured (Advanced Chiropractic Clinic, n.d.).

Studies vary due to methods (Sampson et al., 2010). Talk to ChiroMed doctors to check if it fits.

Wrapping Up

PRP therapy uses your body’s power for detox and cleanup at ChiroMed. Concentrated growth factors speed healing, clear debris, and rebuild tissues. From angiogenesis to macrophages, it sets the stage for clean regeneration. ChiroMed, led by Dr. Jimenez, combines PRP with holistic care for optimal outcomes. For pain or injury, PRP at ChiroMed could aid natural recovery.

References